Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK4323 in Healthy Volunteers and Atopic Dermatitis
NCT03846466Phase 1Terminated
- Sponsor
- Kyowa Kirin
- Start
- Feb 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of KHK4323 in atopic dermatitis (AD) (18 arms), sponsored by Kyowa Kirin. Primary endpoint: Number of participants with adverse events at Day 225. Started Feb 2019; status: terminated.
02
Drugs
KHK4323
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03846466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03846466.